Stock DNA
Pharmaceuticals & Biotechnology
CNY 47,680 Million (Large Cap)
26.00
NA
2.21%
-0.20
8.02%
2.09
Revenue and Profits:
Net Sales:
3,550 Million
(Quarterly Results - Jun 2025)
Net Profit:
462 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-19.25%
0%
-19.25%
6 Months
-3.83%
0%
-3.83%
1 Year
-9.19%
0%
-9.19%
2 Years
-37.45%
0%
-37.45%
3 Years
-43.49%
0%
-43.49%
4 Years
-65.73%
0%
-65.73%
5 Years
-74.32%
0%
-74.32%
Changchun High-Tech Industry (Group) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.20%
EBIT Growth (5y)
-6.60%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.59
Tax Ratio
12.15%
Dividend Payout Ratio
40.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
34.03%
ROE (avg)
21.87%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.09
EV to EBIT
19.11
EV to EBITDA
14.40
EV to Capital Employed
2.35
EV to Sales
3.22
PEG Ratio
NA
Dividend Yield
2.21%
ROCE (Latest)
12.31%
ROE (Latest)
8.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
3,550.20
3,457.70
2.68%
Operating Profit (PBDIT) excl Other Income
766.50
1,318.60
-41.87%
Interest
10.20
4.70
117.02%
Exceptional Items
11.80
-0.00
Consolidate Net Profit
462.50
903.80
-48.83%
Operating Profit Margin (Excl OI)
160.20%
335.20%
-17.50%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 2.68% vs 2.69% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -48.83% vs -32.98% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
13,403.60
14,460.10
-7.31%
Operating Profit (PBDIT) excl Other Income
3,726.40
5,911.00
-36.96%
Interest
38.00
38.10
-0.26%
Exceptional Items
-39.50
-81.00
51.23%
Consolidate Net Profit
2,707.50
4,775.80
-43.31%
Operating Profit Margin (Excl OI)
251.20%
388.50%
-13.73%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -7.31% vs 15.49% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -43.31% vs 13.30% in Dec 2023
About Changchun High-Tech Industry (Group) Co., Ltd. 
Changchun High-Tech Industry (Group) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






